1. Clinicopathologic study of S-1 alone in elderly patients with oral squamous cell carcinoma
   Kenichiro Ishibashi et al, 2023, Journal of Japanese Society of Oral Oncology CrossRef
2. Phase I study of resminostat, an HDAC inhibitor, combined with S-1 in patients with pre-treated biliary tract or pancreatic cancer
   Masafumi Ikeda et al, 2019, Investigational New Drugs CrossRef
3. Germline oncopharmacogenetics, a promising field in cancer therapy
   Chiara Pesenti et al, 2015, Cellular Oncology CrossRef
4. Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
   Nikolaos Tsesmetzis et al, 2018, Cancers CrossRef